However, the correlation between PD-L1 and DRD2 has not been well-investigated in context to human cancer except for one recent study where Paliperidone (a DRD2 antagonist) reduced PD-L1 expression in glioblastoma cells and increased survival in a mouse model of glioblastoma (94). This evidence concerns the gene DRD2 and cancer.